The most important, influential diabetes research of 2017

The past 12 months have seen a lot of excitement in the field of diabetes research, from growing national recognition of the disease to improved methods for treating it. Reader’s Digest compiled a list of the year’s most striking innovations to date.

In 2017 alone:

  • The Medicare Diabetes Prevention Program expanded into a six-month, group-based classroom program that teaches diabetics how to effectively manage their condition.
  • A large-scale study determined type 2 diabetes is—at least partially—attributable to genetics.
  • Reports suggested most types of type 2 diabetes are reversible.
  • Glucose monitors and insulin pumps have come leaps and bounds from their starting points.
  • Scientists discovered type 2 diabetes and cancer risk are closely linked, suggesting diet is even more key than previously thought.
  • The tie between diabetes and heart disease was established as a dangerous and common one.

For the full, comprehensive list, read the Reader’s Digest report below:

""

After graduating from Indiana University-Bloomington with a bachelor’s in journalism, Anicka joined TriMed’s Chicago team in 2017 covering cardiology. Close to her heart is long-form journalism, Pilot G-2 pens, dark chocolate and her dog Harper Lee.

Around the web

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.